Unreported / Non-Citable
Background
Participants in an EssilorLuxottica-sponsored defined-contribution retirement plan sued EssilorLuxottica USA and its ERISA Committee over the plan’s Prudential Guaranteed Income Fund, a stable value investment option backed by Prudential’s general account. The plaintiffs alleged that the fund offered lower crediting rates than comparable investments and allowed Prudential to retain the spread between its investment earnings and the amounts paid to participants.
The plaintiffs asserted that EssilorLuxottica failed to monitor the fund, investigate alternatives, negotiate better terms, and assess risks associated with Prudential’s financial condition. They brought claims for breach of ERISA’s fiduciary duty of prudence, prohibited transactions involving Prudential’s services and compensation, and failure to monitor fiduciaries. EssilorLuxottica moved to dismiss under Rule 12(b)(6).
The Court’s Holding
The court held that the amended complaint did not plausibly allege imprudence. Although the plaintiffs supplied performance data and identified characteristics allegedly shared by their proposed comparator funds, they did not provide enough detail about the comparators’ structures, contractual terms, risk exposures, insurers, or financial condition to establish a meaningful benchmark. Better performance alone did not permit an inference that the Prudential Fund was imprudent, and the allegations about Prudential’s financial risks were not adequately tied to a deficiency in EssilorLuxottica’s selection or monitoring process.
The prohibited-transaction claim also failed because collecting a contractually determined fee is not itself a transaction under ERISA Section 1106(a), and the complaint did not allege that Prudential was already a party in interest when the relevant contract was entered. The derivative monitoring claim failed because the underlying fiduciary-breach claims failed. The court granted the motion to dismiss, dismissed the amended complaint without prejudice, and allowed the plaintiffs 28 days to file a second amended complaint limited to curing the identified deficiencies.
Key Takeaways
- ERISA plaintiffs relying on circumstantial evidence of imprudence must plead facts showing that proposed comparator investments are meaningfully similar, not merely better performing.
- Alleged financial risks must be placed in relevant market context and connected to a specific flaw in the fiduciary’s selection or monitoring process.
- A prohibited-transaction claim must plausibly allege that the service provider was a party in interest when the challenged transaction occurred; later collection of contractually fixed fees is insufficient.
Why It Matters
The decision illustrates the factual detail required to challenge a stable value fund at the pleading stage. Performance comparisons must account for material structural, contractual, and risk differences, while allegations about an insurer’s financial condition must explain how those facts bear on the fiduciary process.
The ruling also emphasizes the importance of identifying the relevant transaction and the service provider’s status at that time when pleading an ERISA prohibited-transaction claim. Because dismissal was without prejudice, the plaintiffs may attempt to supply those missing allegations in an amended pleading.